StockCIK 318306
ABEONA THERAPEUTICS INC. (ABEO): Insider Trades and Fund Holdings
In the past 12 months, ABEONA THERAPEUTICS INC. insiders reported 0 open-market purchases worth $0 and 5 sales worth $296K; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$296KSold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 29, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 29 | Vishwas SeshadriCEO | ▼ SELL | $101K |
| Sep 29 | Joseph Walter VazzanoCFO | ▼ SELL | $47K |
| Sep 29 | Brendan M. O'MalleyGeneral Counsel | ▼ SELL | $35K |
| Sep 29 | Madhav VasanthavadaChief Commercial Officer | ▼ SELL | $25K |
| Sep 1 | Mark AlvinoDirector | ▼ SELL | $88K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Vishwas Seshadri | CEO | 0 | $0 | 1 | $101K |
| Joseph Walter Vazzano | CFO | 0 | $0 | 1 | $47K |
| Brendan M. O'Malley | General Counsel | 0 | $0 | 1 | $35K |
| Madhav Vasanthavada | Chief Commercial Officer | 0 | $0 | 1 | $25K |
| Mark Alvino | Director | 0 | $0 | 1 | $88K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report ABEO
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →